ArticleCureus2025
Laryngeal Cancer in Europe and Its Subregions: A Temporal Epidemiological Analysis Based on Global Burden of Disease Data.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epidemiological Profile and Survival Outcomes of Laryngeal Cancer in Western Greece: A 21-Year Retrospective Cohort Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Laryngeal cancer remains a significant public health issue in Europe, with considerable variation across countries and regions. Evaluating trends in incidence, mortality, and survival indicators such as the mortality-to-incidence ratio (MIR) may provide insights into disparities and guide policy development. The objective of this study was to conduct a 25-year epidemiological data analysis of age-standardized rates (ASRs) for the incidence and mortality of laryngeal cancer, and to compare the MIRs across European countries and subregions (North, South, East, and West Europe), using data from the Global Burden of Disease (GBD) database. Methods We extracted secondary data on laryngeal cancer from the GBD dataset provided by the Institute for Health Metrics and Evaluation (IHME) for the years 1997 to 2021. ASRs for incidence and mortality, as well as MIRs based on these ASRs, were analyzed. Descriptive statistics (mean, median, standard deviation, minimum-maximum range) and linear regression were performed using Microsoft Excel 365. Results All key indicators showed a downward trend over the 25-year period. The average MIR declined from 0.563 in 1997 to 0.459 in 2021 (R² = 96.26%, p < 0.001). Northern Europe improved from 0.448 to 0.355, while Western Europe consistently reported the lowest MIRs (0.388 to 0.326), likely reflecting improved access to specialized oncology services, advanced treatment protocols, and more equitable healthcare delivery. Finland (0.252), France (0.263), Ireland (0.274), Sweden (0.276), and Norway (0.278) had the most favorable MIRs. Eastern Europe, despite improvement (from 0.690 to 0.565), still exhibited the highest MIRs. Southern Europe also showed a decrease (0.575 to 0.465), although countries like Montenegro and Serbia reported the highest incidence rates (up to 9.9 cases per 100,000). Conclusion Substantial geographical disparities were observed in laryngeal cancer incidence, mortality, and management across Europe. Northern countries demonstrate better preventive strategies, while Western Europe shows more effective disease management. These findings underscore the need for targeted public health interventions focusing on prevention, early diagnosis, reducing inequalities, and improving access to quality cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.